IPO Watch: These IPOs have been late bloomers but have come to life in the last fortnight

In the past fortnight the average gain for ASX IPOs in 2021 has gone up from 26% to 31% thanks to a handful of late bloomers.

The cohort has a fair share of both winners and losers from Kuniko (ASX:KKI), up over 900%, to HR tech stock Hiremii (ASX:HMI) which is down 55%.

But other IPOs trod water for a few months before springing to life and such was the case with a handful of companies this past fortnight.

Late bloomer IPOs

One such company is EP&T Global (ASX:EPX) which yesterday went from being 30% underwater to 5% ahead of its IPO price thanks to a financial update.

The software stock helps building owners and operators achieve savings from both cost and carbon footprint perspectives.

It told shareholders it is expecting its Annual Recurring Revenue to be 85% higher by the end of FY22 than the $5.3 million it was at the end of FY21.

Another 2021 ASX IPO that has been a late bloomer is Australasian Gold (ASX:A8G).

In recent days it has kicked off exploration activities at the ‘Mt Peake’ lithium project in the Northern Territory and completed a $2.5 million capital raising headed by Chinese lithium investors Shandong and Tangshan.

And the first IPO of the year, cervical cancer screening company TruScreen (ASX:TRU) went from negative to positive territory this week.

The company announced that its TruScreen device is now equipped with an improved cyber security upgrade, while flagging expanded distribution opportunities in China.

For other IPOs, it’s been a slow and steady journey – but slow and steady has been winning the race.

Discount retailer Best & Less (ASX:BST) for example is up 55% since listing, bouyed by a stellar FY21 result.

While uranium listee 92 Energy (ASX:92E) has attracted attention due to the rise in the spot price of uranium and is up 285% since its April listing, NexGen Energy (ASX:NXG) has been a solid performer too.

NexGen, which also has a project in Canada, joined the ASX in July and is up over 50% since listing.
 

Here’s a list of all 2021’s ASX IPOs…

Upcoming listings

Despite this year’s list of ASX IPOs set to surpass 130, the Christmas rush of listings is still expected to be as busy as usual.

The biggest IPO to hit the ASX in several years will list on Tuesday – GQG Partners (ASX:GQG), which is a Florida-based fund manager.

The two most noteworthy IPOs in November include underwear maker Step One and neobank Judo.

But there will be several more resources listings as well as a couple of biotechs.

One of these is Paul Hopper’s latest venture, Radiopharm Theranostics, which is targeting cancer with radiation therapy, listing on November 25. Another is regenerative medicine company Tissue Repair, which will list on November 15.